Understanding diabetic teratogenesis: Where are we now and where are we going?
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Maternal pregestational diabetes (type 1 or type 2) poses an increased risk for a broad spectrum of birth defects. To our knowledge, this problem first came to the attention of the Teratology Society at the 14th Annual Meeting in Vancouver, B.C. in 1974, with a presentation by Lewis Holmes, “Etiologic heterogeneity of neural tube defects”. Although advances in the control of diabetes in the decades since the discovery of insulin in the 1920's have reduced the risk for birth defects during diabetic pregnancy, the increasing incidence of diabetes among women of childbearing years indicates that this cause of birth defects is a growing public health concern. Major advances in understanding how a disease of maternal fuel metabolism can interfere with embryogenesis of multiple organ systems have been made in recent years. In this review, we trace the history of the study of diabetic teratogenesis and discuss a model in which tissue‐specific developmental control genes are regulated at specific times in embryonic development by glucose metabolism. The major function of such genes is to suppress apoptosis, perhaps to preserve proliferative capability, and inhibit premature senescence. Birth Defects Research (Part A), 2010. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781 · cited 1×
“Genetic manipulations that block formation of the circulatory system produce excess embryo hypoxia and cause NTDs (Carmeliet et al., 1996; Maltepe et al., 1997; Tian et al., 1998; Yao et al., 1998; Kotch et al., 1999).”
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 2×
“There is emerging evidence that p53 promotes aerobic glucose metabolism (Ma et al., 2007). p53 also inhibits activity of the muscle isoform of the glycolytic enzyme, phosphoglycerate mutase (PGMm), that is expressed in undifferentiated cells (Kondoh et al., 2005).”
Mills, J. L., Simpson, J. L., Driscoll, S. G., Jovanovic-Peterson, L., Van Allen, M., Aarons, J. H., Metzger, B., Bieber, F. R., Knopp, R. H., Holmes, L. B., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192501 · Cited by 402 · cited 1×
“On the other hand, spontaneous abortions continued to be increased in poorly controlled diabetes (Miodovnik et al., 1986; Mills et al., 1988; Miodovnik et al., 1990).”
A High Glycolytic Flux Supports the Proliferative Potential of Murine Embryonic Stem Cells
Kondoh, H., Lleonart, M. E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D., Gil, J., & Beach, D. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1467 · Cited by 325 · cited 1×
“A high glycolytic flux and low mitochondrial oxygen consumption promote proliferation and inhibit senescence (Kondoh et al., 2007).”
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Paddenberg, R., Ishaq, B., Goldenberg, A., Faulhammer, P., Rose, F., Weissmann, N., Braun-Dullaeus, R. C., & Kummer, W. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00149.2002 · Cited by 184 · cited 2×
“Hypoxia can increase superoxide production by inhibiting mitochondrial complexes I, II, and III (Paddenberg et al., 2003).”
InfluentialHagay, Z. J., Weiss, Y., Zusman, I., Peled-Kamar, M., Reece, E. A., Eriksson, U. J., & Groner, Y. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91323-8 · Cited by 149 · cited 1×
“Second, transgenic overexpression of human Cu/Zn-SOD reduced malformations in embryos of STZ-diabetic mice (Hagay et al., 1995).”
High glucose concentration inhibits migration of rat cranial neural crest cells in vitro
Suzuki, N., Svensson, K., & Eriksson, U. J. (1996) · Diabetologia · doi:10.1007/bf00400671 · Cited by 77
Cited by
Microtia: Epidemiology and genetics
Luquetti, D. V., Heike, C. L., Hing, A. V., Cunningham, M. L., & Cox, T. C. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34352 · Cited by 457
Bell, R., Glinianaia, S. V., Tennant, P. W. G., Bilous, R. W., & Rankin, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2455-y · Cited by 224
N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes
Moazzen, H., Lu, X., Ma, N. L., Velenosi, T. J., Urquhart, B. L., Wisse, L. J., Gittenberger-de Groot, A. C., & Feng, Q. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-46 · Cited by 111
Maternal Diet Modulates Placenta Growth and Gene Expression in a Mouse Model of Diabetic Pregnancy
Kappen, C., Kruger, C., MacGowan, J., & Salbaum, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038445 · Cited by 36
“However, it is now becoming clear that overnutrition and excess of particular nutrients, such as with maternal obesity or diabetes, are also detrimental [3,4,5,6].”
Background
Metadata
- Authors
- Zabihi, S., & Loeken, M. R.
- Venue
- Birth Defects Research Part A: Clinical and Molecular Teratology
- Publisher
- Wiley
- Published
- 2010-08-12
- Volume
- 88
- Issue
- 10
- Pages
- 779-790
- ISSN
- 1542-0752 (ISSN-L)
- 1542-0760
- OpenAlex
- W1512266982
- Cited by
- 98
- References
- 10
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.